Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 751571, 10 pages
http://dx.doi.org/10.1155/2015/751571
Review Article

The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life

1Department of Obstetrics Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero Universitaria Policlinico of Modena, Via del Pozzo 71, 41124 Modena, Italy
2Department of Oncology, Haematology and Respiratory Disease, Azienda Ospedaliero Universitaria Policlinico of Modena, Via del Pozzo 71, 41124 Modena, Italy
3Department of Laboratory Medicine and Pathology, Azienda Ospedaliero Universitaria Policlinico of Modena, Via del Pozzo 71, 41124 Modena, Italy

Received 3 April 2015; Accepted 18 August 2015

Academic Editor: Ivo Meinhold-Heerlein

Copyright © 2015 Giovanni Grandi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Bulun, “Endometriosis,” The New England Journal of Medicine, vol. 360, no. 3, pp. 268–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Lapp, “ACOG issues recommendations for the management of endometriosis,” American Family Physician, vol. 62, no. 6, pp. 1431–1434, 2000. View at Google Scholar · View at Scopus
  3. G. Grandi, A. Xholli, S. Ferrari, M. Cannoletta, A. Volpe, and A. Cagnacci, “Intermenstrual pelvic pain, quality of life and mood,” Gynecologic and Obstetric Investigation, vol. 75, no. 2, pp. 97–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. N. Heidemann, D. Hartwell, C. H. Heidemann, and K. M. Jochumsen, “The relation between endometriosis and ovarian cancer—a review,” Acta Obstetricia et Gynecologica Scandinavica, vol. 93, no. 1, pp. 20–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Sampson, “Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity,” American Journal of Obstetrics & Gynecology, vol. 14, pp. 422–469, 1927. View at Google Scholar
  6. J. S. Sanfilippo, N. G. Wakim, K. N. Schikler, and M. A. Yussman, “Endometriosis in association with uterine anomaly,” American Journal of Obstetrics & Gynecology, vol. 154, no. 1, pp. 39–43, 1986. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Salamanca and E. Beltran, “Subendometrial contractility in menstrual phase visualized by transvaginal sonography in patients with endometriosis,” Fertility and Sterility, vol. 64, no. 1, pp. 193–195, 1995. View at Google Scholar · View at Scopus
  8. S. Jenkins, D. L. Olive, and A. F. Haney, “Endometriosis: pathogenetic implications of the anatomic distribution,” Obstetrics and Gynecology, vol. 67, no. 3, pp. 335–338, 1986. View at Google Scholar · View at Scopus
  9. M. K. Cho, C. H. Kim, and S. T. Oh, “Endometriosis in a patient with Rokitansky-Kuster-Hauser syndrome,” Journal of Obstetrics and Gynaecology Research, vol. 35, no. 5, pp. 994–996, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Nisolle and J. Donnez, “Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities,” Fertility and Sterility, vol. 68, no. 4, pp. 585–596, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Kurman and I.-M. Shih, “The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory,” The American Journal of Surgical Pathology, vol. 34, no. 3, pp. 433–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. E. Hughesdon, “The structure of endometrial cysts of the ovary,” Journal of Obstetrics and Gynecology British Empire, vol. 44, pp. 69–84, 1957. View at Google Scholar
  13. I. A. Brosens, P. J. Puttemans, and J. Deprest, “The endoscopic localization of endometrial implants in the ovarian chocolate cyst,” Fertility and Sterility, vol. 61, no. 6, pp. 1034–1038, 1994. View at Google Scholar · View at Scopus
  14. F. Nezhat, C. Nezhat, C. J. Allan, D. A. Metzger, and D. L. Sears, “Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis,” Journal of Reproductive Medicine, vol. 37, no. 9, pp. 771–776, 1992. View at Google Scholar · View at Scopus
  15. P. Vercellini, E. Somigliana, P. Vigano, A. Abbiati, G. Barbara, and L. Fedele, “‘Blood on the Tracks’ from corpora lutea to endometriomas,” BJOG, vol. 116, no. 3, pp. 366–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Nisolle and J. Donnez, “Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities,” Fertility and Sterility, vol. 68, no. 4, pp. 585–596, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Tanase, N. Furukawa, H. Kobayashi, and T. Matsumoto, “Malignant transformation from endometriosis to atypical endometriosis and finally to endometrioid adenocarcinoma within 10 years,” Case Reports in Oncology, vol. 6, no. 3, pp. 480–484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Czernobilsky and W. J. Morris, “A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes,” Obstetrics and Gynecology, vol. 53, no. 3, pp. 318–323, 1979. View at Google Scholar · View at Scopus
  19. E. J. Thomas and I. G. Campbell, “Evidence that endometriosis behaves in a malignant manner,” Gynecologic and Obstetric Investigation, vol. 50, no. 1, pp. 2–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Van Gorp, F. Amant, P. Neven, I. Vergote, and P. Moerman, “Endometriosis and the development of malignant tumours of the pelvis: a review of literature,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 18, no. 2, pp. 349–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Somigliana, P. Vercellini, P. Vigano, A. Abbiati, L. Benaglia, and L. Fedele, “Endometriosis and estroprogestins: the chicken or the egg causality dilemma,” Fertility and Sterility, vol. 95, no. 1, pp. 431–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Vercellini, S. De Matteis, E. Somigliana, L. Buggio, M. P. Frattaruolo, and L. Fedele, “Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis,” Acta Obstetricia et Gynecologica Scandinavica, vol. 92, no. 1, pp. 8–16, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Köhler, T. A. Faustmann, C. Gerlinger, C. Seitz, and A. O. Mueck, “A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis,” International Journal of Gynecology and Obstetrics, vol. 108, no. 1, pp. 21–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Grandi, A. Xholli, A. Napolitano, F. Palma, and A. Cagnacci, “Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive a patient-preference prospective 24-week pilot study,” Reproductive Sciences, vol. 22, no. 5, pp. 626–632, 2015. View at Publisher · View at Google Scholar
  25. A. D. DiVasta and M. R. Laufer, “The use of gonadotropin releasing hormone analogues in adolescent and young patients with endometriosis,” Current Opinion in Obstetrics & Gynecology, vol. 25, no. 4, pp. 287–292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Rizk, A. S. Fischer, H. A. Lotfy et al., “Recurrence of endometriosis after hysterectomy,” Facts, Views & Vision in ObGyn, vol. 6, no. 4, pp. 219–227, 2014. View at Google Scholar
  27. N. Vlahos, A. Vlachos, O. Triantafyllidou, N. Vitoratos, and G. Creatsas, “Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study,” Fertility and Sterility, vol. 100, no. 5, pp. 1337–1342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Seracchioli, M. Mabrouk, C. Frascà et al., “Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial,” Fertility and Sterility, vol. 93, no. 1, pp. 52–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Seracchioli, M. Mabrouk, C. Frascà, L. Manuzzi, L. Savelli, and S. Venturoli, “Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial,” Fertility and Sterility, vol. 94, no. 2, pp. 464–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Thigpen, “A rational approach to the management of recurrent or persistent ovarian carcinoma,” Clinical Obstetrics and Gynecology, vol. 55, no. 1, pp. 114–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. C. Mok, J. Kwong, W. R. Welch et al., “Etiology and pathogenesis of epithelial ovarian cancer,” Disease Markers, vol. 23, no. 5-6, pp. 367–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Prat, “New insights into ovarian cancer pathology,” Annals of Oncology, vol. 23, supplement 10, Article ID mds300, pp. x111–x117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D. W. Cramer and H. Xu, “Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer,” Annals of Epidemiology, vol. 5, no. 4, pp. 310–314, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. M. F. Fathalla, “Incessant ovulation—a factor in ovarian neoplasia?” The Lancet, vol. 298, no. 7716, p. 163, 1971. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Cibula, A. Gompel, A. O. Mueck et al., “Hormonal contraception and risk of cancer,” Human Reproduction Update, vol. 16, no. 6, pp. 631–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Schildkraut, P. J. Schwingl, E. Bastos, A. Evanoff, and C. Hughes, “Epithelial ovarian cancer risk among women with polycystic ovary syndrome,” Obstetrics and Gynecology, vol. 88, no. 4, pp. 554–559, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. A. K. Folkins, E. A. Jarboe, M. H. Roh, and C. P. Crum, “Precursors to pelvic serous carcinoma and their clinical implications,” Gynecologic Oncology, vol. 113, no. 3, pp. 391–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Cibula, M. Widschwendter, O. Májek, and L. Dusek, “Tubal ligation and the risk of ovarian cancer: review and meta-analysis,” Human Reproduction Update, vol. 17, no. 1, pp. 55–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Vercellini, P. Crosignani, E. Somigliana et al., “The ‘incessant menstruation’ hypothesis: a mechanistic ovarian cancer model with implications for prevention,” Human Reproduction, vol. 26, no. 9, pp. 2262–2273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. R. B. Scott, “Malignant changes in endometriosis.,” Obstetrics and Gynecology, vol. 2, no. 3, pp. 283–289, 1953. View at Google Scholar · View at Scopus
  42. L. A. Brinton, G. Gridley, I. Persson, J. Baron, and A. Bergqvist, “Cancer risk after a hospital discharge diagnosis of endometriosis,” American Journal of Obstetrics & Gynecology, vol. 176, no. 3, pp. 572–579, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Erzen and J. Kovacic, “Relationship between endometriosis and ovarian cancer,” European Journal of Gynaecological Oncology, vol. 19, pp. 553–555, 1998. View at Google Scholar
  44. S. Ogawa, T. Kaku, S. Amada et al., “Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study,” Gynecologic Oncology, vol. 77, no. 2, pp. 298–304, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Melin, P. Sparén, I. Persson, and A. Bergqvist, “Endometriosis and the risk of cancer with special emphasis on ovarian cancer,” Human Reproduction, vol. 21, no. 5, pp. 1237–1242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. C. L. Pearce, C. Templeman, M. A. Rossing et al., “Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies,” The Lancet Oncology, vol. 13, no. 4, pp. 385–394, 2012. View at Publisher · View at Google Scholar
  47. P. Viganó, E. Somigliana, I. Chiodo, A. Abbiati, and P. Vercellini, “Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis,” Human Reproduction Update, vol. 12, no. 1, pp. 77–89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. M. J. Worley Jr., W. R. Welch, R. S. Berkowitz, and S.-W. Ng, “Endometriosis-associated ovarian cancer: a review of pathogenesis,” International Journal of Molecular Sciences, vol. 14, no. 3, pp. 5367–5379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. R. J. Kurman, “Origin and molecular pathogenesis of ovarian high-grade serous carcinoma,” Annals of Oncology, vol. 24, supplement 10, pp. x16–x21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. R. J. Kurman and I.-M. Shih, “Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications,” International Journal of Gynecological Pathology, vol. 27, no. 2, pp. 151–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. K. C. Wiegand, S. P. Shah, O. M. Al-Agha et al., “ARID1A mutations in endometriosis-associated ovarian carcinomas,” The New England Journal of Medicine, vol. 363, no. 16, pp. 1532–1543, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Jones, T.-L. Wang, I.-M. Shih et al., “Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma,” Science, vol. 330, no. 6001, pp. 228–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. I. K. Kolasa, A. Rembiszewska, A. Janiec-Jankowska et al., “PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations,” Gynecologic Oncology, vol. 103, no. 2, pp. 692–697, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Palacios and C. Gamallo, “Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas,” Cancer Research, vol. 58, no. 7, pp. 1344–1347, 1998. View at Google Scholar · View at Scopus
  55. J. Madore, F. Ren, A. Filali-Mouhim et al., “Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma,” The Journal of Pathology, vol. 220, no. 3, pp. 392–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Banz, U. Ungethuem, R.-J. Kuban, K. Diedrich, E. Lengyel, and D. Hornung, “The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer,” Fertility and Sterility, vol. 94, no. 4, pp. 1212–1217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Cornen, J. Adelaide, F. Bertucci et al., “Mutations and deletions of ARID1A in breast tumors,” Oncogene, vol. 31, no. 38, pp. 4255–4256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Yamamoto, H. Tsuda, M. Takano, S. Tamai, and O. Matsubara, “Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations,” Modern Pathology, vol. 25, no. 4, pp. 615–624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Popovic and J. D. Licht, “Emerging epigenetic targets and therapies in cancer medicine,” Cancer Discovery, vol. 2, no. 5, pp. 405–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. E. P. Samartzis, A. Noske, K. J. Dedes, D. Fink, and P. Imesch, “ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas,” International Journal of Molecular Sciences, vol. 14, no. 9, pp. 18824–18849, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Liu, H. Cheng, T. M. Roberts, and J. J. Zhao, “Targeting the phosphoinositide 3-kinase pathway in cancer,” Nature Reviews Drug Discovery, vol. 8, no. 8, pp. 627–644, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. X. Yin, M. E. Pavone, Z. Lu, J. Wei, and J. J. Kim, “Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 1, pp. E35–E43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Laudanski, J. Szamatowicz, O. Kowalczuk, M. Kuźmicki, M. Grabowicz, and L. Chyczewski, “Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis,” Human Reproduction, vol. 24, no. 8, pp. 1880–1890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. N. Sato, H. Tsunoda, M. Nishida et al., “Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary,” Cancer Research, vol. 60, no. 24, pp. 7052–7056, 2000. View at Google Scholar · View at Scopus
  65. J. P. Orezzoli, A. H. Russell, E. Oliva, M. G. Del Carmen, J. Eichhorn, and A. F. Fuller, “Prognostic implication of endometriosis in clear cell carcinoma of the ovary,” Gynecologic Oncology, vol. 110, no. 3, pp. 336–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. I. Gounaris, D. S. Charnock-Jones, and J. D. Brenton, “Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?” Journal of Pathology, vol. 225, no. 2, pp. 157–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. J. A. Engelman, “Targeting PI3K signalling in cancer: opportunities, challenges and limitations,” Nature Reviews Cancer, vol. 9, no. 8, pp. 550–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. V. Auner, G. Kriegshäuser, D. Tong et al., “KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay,” BMC Cancer, vol. 9, article 111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Mayr, A. Hirschmann, U. Löhrs, and J. Diebold, “KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants,” Gynecologic Oncology, vol. 103, no. 3, pp. 883–887, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. J. T. Geyer, M. A. López-García, C. Sánchez-Estevez et al., “Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases,” The American Journal of Surgical Pathology, vol. 33, no. 8, pp. 1157–1163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. C. J. R. Stewart, Y. Leung, M. D. Walsh, R. J. Walters, J. P. Young, and D. D. Buchanan, “KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis,” Human Pathology, vol. 43, no. 8, pp. 1177–1183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. D. M. Dinulescu, T. A. Ince, B. J. Quade, S. A. Shafer, D. Crowley, and T. Jacks, “Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer,” Nature Medicine, vol. 11, no. 1, pp. 63–70, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. C. M. Kyama, L. Overbergh, S. Debrock et al., “Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis,” Fertility and Sterility, vol. 85, no. 6, pp. 1667–1675, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. K. M. Zeitoun and S. E. Bulun, “Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target,” Fertility and Sterility, vol. 72, no. 6, pp. 961–969, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Zeitoun, K. Takayama, H. Sasano et al., “Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 12, pp. 4474–4480, 1998. View at Google Scholar · View at Scopus
  76. R. A. Soslow, “Histologic subtypes of ovarian carcinoma: an overview,” International Journal of Gynecological Pathology, vol. 27, no. 2, pp. 161–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Mandai, K. Yamaguchi, N. Matsumura, T. Baba, and I. Konishi, “Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management,” International Journal of Clinical Oncology, vol. 14, no. 5, pp. 383–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Cuff and T. A. Longacre, “Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type,” The American Journal of Surgical Pathology, vol. 36, no. 5, pp. 688–695, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. E. Högnäs, A. Kauppila, E. Pukkala, and J. S. Tapanainen, “Cancer risk in women with 10 or more deliveries,” Obstetrics and Gynecology, vol. 123, no. 4, pp. 811–816, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. P. C. Hannaford, S. Selvaraj, A. M. Elliott, V. Angus, L. Iversen, and A. J. Lee, “Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners' oral contraception study,” British Medical Journal, vol. 335, article 651, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Vessey, D. Yeates, and S. Flynn, “Factors affecting mortality in a large cohort study with special reference to oral contraceptive use,” Contraception, vol. 82, no. 3, pp. 221–229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. Collaborative Group on Epidemiological Studies of Ovarian Cancer, “Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls,” The Lancet, vol. 371, no. 9609, pp. 303–314, 2008. View at Publisher · View at Google Scholar
  83. F. Modugno, R. B. Ness, G. O. Allen, J. M. Schildkraut, F. G. Davis, and M. T. Goodman, “Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis,” American Journal of Obstetrics & Gynecology, vol. 191, no. 3, pp. 733–740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Green, D. Purdie, L. Green, M. L. Dick, C. Bain, and V. Siskind, “Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group,” Australian and New Zealand Journal of Public Health, vol. 21, pp. 337–340, 1997. View at Google Scholar